Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vickers

Showing results (651-660 of 665) with videos related to

Pageof 67
Sort By:
JAMA Surgery|July 2, 2025
Rizedisben in Minimally Invasive Surgery: A Nonrandomized Clinical TrialSamuel A Gold, Maria M Pere, Melissa Assel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
Prostate cancer early detection, version 1.2014. Featured updates to the NCCN GuidelinesPeter R Carroll, J Kellogg Parsons, Gerald Andriole, et al.
European Urology Open Science|September 11, 2024
Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional StudyRiccardo Leni, Emily A Vertosick, Roderick C N van den Bergh, et al.
European Urology Focus|July 21, 2017
Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical CystectomyLuis A Kluth, Evanguelos Xylinas, Malte Rieken, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2015
NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015Peter R Carroll, J Kellogg Parsons, Gerald Andriole, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
CD4 T cells and CD8α+ lymphocytes are necessary for intravenous BCG-induced protection against tuberculosis in macaquesAndrew W Simonson, Joseph J Zeppa, Allison N Bucsan, et al.
The Journal of Experimental Medicine|February 6, 2025
Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8α+ lymphocytesAndrew W Simonson, Joseph J Zeppa, Allison N Bucsan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016Peter R Carroll, J Kellogg Parsons, Gerald Andriole, et al.
Nature Medicine|April 24, 2019
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET studyDominic G Rothwell, Mahmood Ayub, Natalie Cook, et al.
Journal of the National Cancer Institute|September 26, 2025
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordantSimone Scuderi, , Amy L Tin, et al.
Pageof 67

Showing results (651-660 of 665) with videos related to

Sort By:
Pageof 67
JAMA Surgery|July 2, 2025
Rizedisben in Minimally Invasive Surgery: A Nonrandomized Clinical TrialSamuel A Gold, Maria M Pere, Melissa Assel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
Prostate cancer early detection, version 1.2014. Featured updates to the NCCN GuidelinesPeter R Carroll, J Kellogg Parsons, Gerald Andriole, et al.
European Urology Open Science|September 11, 2024
Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional StudyRiccardo Leni, Emily A Vertosick, Roderick C N van den Bergh, et al.
European Urology Focus|July 21, 2017
Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical CystectomyLuis A Kluth, Evanguelos Xylinas, Malte Rieken, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2015
NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015Peter R Carroll, J Kellogg Parsons, Gerald Andriole, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
CD4 T cells and CD8α+ lymphocytes are necessary for intravenous BCG-induced protection against tuberculosis in macaquesAndrew W Simonson, Joseph J Zeppa, Allison N Bucsan, et al.
The Journal of Experimental Medicine|February 6, 2025
Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8α+ lymphocytesAndrew W Simonson, Joseph J Zeppa, Allison N Bucsan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016Peter R Carroll, J Kellogg Parsons, Gerald Andriole, et al.
Nature Medicine|April 24, 2019
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET studyDominic G Rothwell, Mahmood Ayub, Natalie Cook, et al.
Journal of the National Cancer Institute|September 26, 2025
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordantSimone Scuderi, , Amy L Tin, et al.
Pageof 67